Log in
Enquire now
‌

US Patent 7846689 Compositions of aminoacyl-tRNA synthetase and uses thereof

Patent 7846689 was granted and assigned to Ambrx on December, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Current Assignee
Ambrx
Ambrx
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
78466891
Patent Inventor Names
Andrew Paulsel1
Ho Sung Cho1
Date of Patent
December 7, 2010
1
Patent Application Number
127241741
Date Filed
March 15, 2010
1
Patent Citations Received
‌
US Patent 11786578 Modified relaxin polypeptides and their uses
‌
US Patent 11851662 Methods and compositions for promoting non-natural amino acid-containing protein production
2
Patent Primary Examiner
‌
Manjunath N. Rao
1
Patent abstract

Compositions and methods of producing components of protein biosynthetic machinery that include orthogonal tRNA's, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNA's/synthetases are provided. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins using these orthogonal pairs.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7846689 Compositions of aminoacyl-tRNA synthetase and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.